• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

Recent Advances in the Study of N-Decanoylmorpholine (CAS: 5299-65-0) in Chemical Biology and Pharmaceutical Research

N-Decanoylmorpholine (CAS: 5299-65-0) is a synthetic compound that has garnered increasing attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a versatile building block in drug design, its interactions with biological targets, and its utility in various formulations. This research brief consolidates the latest findings on N-Decanoylmorpholine, providing insights into its mechanisms of action, pharmacological effects, and emerging applications.

A key area of investigation has been the compound's role as a surfactant and solubilizing agent in pharmaceutical formulations. Studies published in 2023 demonstrate that N-Decanoylmorpholine exhibits excellent solubilizing properties for poorly water-soluble drugs, making it a promising candidate for enhancing drug bioavailability. Its amphiphilic nature allows it to interact with both hydrophobic and hydrophilic molecules, facilitating the formation of stable micelles and improving drug delivery systems.

Recent structural-activity relationship (SAR) studies have shed light on the importance of the morpholine ring and decanoyl chain in N-Decanoylmorpholine's biological activity. Researchers have found that modifications to these moieties can significantly alter the compound's pharmacokinetic properties and target specificity. Computational modeling and molecular docking studies have further elucidated its potential binding sites on various enzyme targets, particularly in the context of anti-inflammatory and antimicrobial applications.

In the realm of antimicrobial research, N-Decanoylmorpholine has shown promising activity against drug-resistant bacterial strains. A 2024 study published in the Journal of Medicinal Chemistry reported that derivatives of N-Decanoylmorpholine exhibited potent inhibitory effects against methicillin-resistant Staphylococcus aureus (MRSA) by disrupting bacterial cell membrane integrity. These findings suggest potential applications in developing novel antibiotics to combat antimicrobial resistance.

The compound's role in neurodegenerative disease research has also emerged as a significant area of investigation. Preliminary studies indicate that N-Decanoylmorpholine derivatives may modulate key pathways involved in neuroinflammation and protein aggregation, which are hallmarks of conditions such as Alzheimer's disease. While these findings are still in early stages, they highlight the compound's potential as a scaffold for developing neuroprotective agents.

From a synthetic chemistry perspective, recent advancements have focused on developing more efficient and sustainable methods for producing N-Decanoylmorpholine. Green chemistry approaches utilizing biocatalysts and continuous flow systems have demonstrated improved yields and reduced environmental impact compared to traditional synthetic routes. These methodological improvements are particularly relevant as the pharmaceutical industry moves toward more sustainable manufacturing practices.

As research on N-Decanoylmorpholine continues to evolve, several challenges and opportunities have been identified. While its versatility is well-established, further studies are needed to fully characterize its safety profile and optimize its therapeutic potential. Additionally, the development of more selective derivatives could enhance its specificity for particular biological targets. The coming years are likely to see increased translational research efforts to bridge the gap between laboratory findings and clinical applications of this promising compound.

• 93920-22-0(Morpholine,4-(1-oxoisooctadecyl)- (9CI))
• 5299-68-3(1-Hexadecanone,1-(4-morpholinyl)-)
• 5299-54-7(Morpholine, 4-(1-oxooctadecyl)-)
• 5327-51-5(1-Butanone,1-(4-morpholinyl)-)
• 22342-18-3(1-Pentanone,1-(4-morpholinyl)-)
• 32972-24-0(1-Undecanone,1-(4-morpholinyl)-)
• 101831-42-9(1-Tridecanone,1-(4-morpholinyl)-)
• 5421-70-5(Morpholine,4,4'-(1,6-dioxo-1,6-hexanediyl)bis- (9CI))
• 5299-64-9(N-Nonanoylmorpholine)
• 17598-10-6( )